Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.02

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $10.8 million, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• C3 AI (AI) call put ratio 1.6 calls to 1 put into quarter results
• Gold.com (GOLD) call put ratio 2.4 calls to 1 put into quarter results